Abstract: A medical registration training component executing within a medical registration system performs a training medical registration operation on a pair of medical studies. Responsive to the medical registration training system determining that the training medical registration operation succeeds, the medical registration training system records a medical registration instance for the pair of medical studies in a medical registration history and marks the medical registration instance as a positive instance in the medical registration history. Responsive to the medical registration training system determining that the training medical registration operation requires correction, the medical registration training system records a medical registration instance for the pair of medical studies in the medical registration history and marks the medical registration instance as a negative instance in the medical registration history.

Abstract: A medcal registration training component executing within a medical registration system performs a training medical registration operation on a pair of medical studies. Responsive to the medical registration training system determining that the training medical registration operation succeeds, the medical registration training system records a medical registration instance for the pair of medical studies in a medical registration history and marks the medical registration instance as a positive instance in the medical registration history. Responsive to the medical registration training system determining that the training medical registration operation requires correction, the medical registration training system records a medical registration instance for the pair of medical studies in the medical registration history and marks the medical registration instance as a negative instance in the medical registration history.

Abstract: A method is provided. The method includes forming a first to third gate lines on a substrate, the second gate line formed between the first and third gate lines; forming a gate isolation region to cut the first to third gate lines into two first sub gate lines, two second sub gate lines and two third sub gate lines, respectively; forming a first gate contact on one of the two first sub gate lines; forming a second gate contact on the two second sub gate lines; forming a third gate contact on one of the two third sub gate lines; forming a first metal line to connect the first and third gate contacts; and forming a second metal line. The first to third gate lines extend in a first direction, and the gate isolation region extends in a second direction different from the first direction.

Abstract: A method for display box management is provided. One method includes identifying a screen on which a display box is located, setting an attribute of the display box according to the identified screen, and displaying data in the display box according to the attribute of the display box.

Abstract: Provided is a functional composition for preventing an Alzheimer's disease, in which the composition includes heat-treated salt that is heat-treated at 800° C. to 1200° C. as an effective component and other pharmaceutically or sitologically acceptable components. The composition can prevent an Alzheimer's disease by effectively blocking the cause path of an Alzheimer's disease in a human body.

Abstract: The present invention relates to a peptide for preventing or treating inflammatory diseases and a use thereof. According to the novel dimeric peptide according to the present invention, it is possible to not only exhibit an excellent therapeutic effect through anti-inflammatory action but also have a very small-sized peptide, thereby minimizing side effects due to the administration of external substances and will be expected to be used as an active substance that can replace existing therapeutic agents for inflammatory diseases.

Abstract: Systems on chips are provided. A system on chip (SoC) includes a first gate line, a second gate line and a third gate line extending in a first direction, a gate isolation region cutting the first gate line, the second gate line and the third gate line and extending in a second direction across the first direction, a first gate contact formed on the second gate line arranged between the first gate line and the third gate line, and electrically connecting the cut second gate line, a second gate contact formed on the first gate line, a third gate contact formed on the third gate line, a first metal line electrically connecting the second gate contact and the third gate contact, and a second metal line electrically connected to the first gate contact.

Abstract: The present invention relates to a novel amino-phenyl-sulfonyl-acetate derivative or a pharmaceutically acceptable salt thereof; and a pharmaceutical composition for preventing or treating diabetes comprising the same as an active ingredient.

Abstract: Topological evolution of a lesion within a time series of medical imagery is provided. In various embodiments, a time series of medical images is read. Each of the images depicts a subject anatomy and a lesion. The lesion has a size and a contour within each of the medical images. At least one anatomical label is read for the subject anatomy within each of the plurality of images. Based upon the contour of the lesion within each of the medical images and based on the at least one anatomical label, a further contour of the lesion is predicted outside of the time series.

Abstract: The present invention relates to a peptide for preventing or treating inflammatory diseases and a use thereof. According to the novel dimeric or trimeric peptide according to the present invention, it is possible to not only exhibit an excellent therapeutic effect through anti-inflammatory action but also have a very small-sized peptide, thereby minimizing side effects due to the administration of external substances. Therefore, it is expected that the peptide can be used as an active substance that can replace existing therapeutic agents for inflammatory diseases.

Abstract: Disclosed are a phosphor composition and a light emitting apparatus including the same. The phosphor composition has a compositional formula of AzCxO12:RE, wherein the z is 0?z?3, the x is 0?x?5, the A includes at least one selected from the group consisting of Y, Sc, Gd and Lu, the C includes at least one selected from the group consisting of B, Al and Ga, and the RE includes at least one selected from the group consisting of Eu, Ce, Sm, Yb, Dy, Gd, Tm and Lu. The light emitting apparatus includes the phosphor composition.

Abstract: A touch sensing device may include: a pre-processing unit configured to reduce common signal noise and frequency components higher than a preset cut-off frequency from a pair of signals outputted from a touch panel, in response to a driving signal; and an attenuation unit configured to attenuate a frequency of a preset frequency region in an output signal of the pre-processing unit, and output a sensing signal.

Abstract: An electronic device and a method are provided. The electronic device can include a motion sensor, a heart rate monitor sensor, and a processor functionally coupled with the motion sensor and the heart rate monitor sensor. The processor can be configured to obtain first motion sensor data for a first duration using the motion sensor, obtain first heartbeat data for the first duration using the heart rate monitor sensor, determine an exercise type based on the first motion sensor data, determine a heartbeat prediction range based on at least one of the first motion sensor data, the exercise type, and the first heartbeat data, obtain second heartbeat data for a second duration using the heart rate monitor sensor, determine whether the second heartbeat data falls within the heartbeat prediction range, and determine heartbeat data of the second duration based on the determination result.

Abstract: An electronic device is provided. The electronic device includes a touchscreen, at least one processor electrically connected with the touchscreen, and a memory electrically connected with the processor. The memory may store instructions executed to enable the at least one processor to display a first window for running a first application and a second window for running a second application on the touchscreen, display a virtual keypad on a portion of the first window and a portion of the second window corresponding to a first input to a focused window of the first window and the second window, and vary a size of the virtual keypad corresponding to a second input to the virtual keypad.

Abstract: Multiple algorithm lesion segmentation using an atlas is provided. In various embodiments, a plurality of medical images are read from an image repository. Each of the plurality of medical images has a source modality. Each of the plurality of medical images is registered to an anatomical atlas. An anatomical region depicted in each of the plurality of medical images is determined thereby. Based upon the source modality and the anatomical region depicted in each of the plurality of medical images, one of a plurality of segmentation algorithms is selected for each of the plurality of medical images. The selected segmentation algorithms are applied to each of the plurality of medical images. The results of the selected segmentation algorithms are displayed.

Abstract: The present specification relates to a conductive structure body, a method for manufacturing the same, and an electrode and an electronic device including the conductive structure body.

Abstract: The present invention relates to phthalazinone derivatives, including pharmaceutical compositions and for the preparation of phthalazinone derivatives. And more particularly the present invention provided a pharmaceutical composition of phthalazinone derivatives for inhibiting activity of the Poly(ADP-riboside) polymerase enzyme.

Abstract: An integrated circuit (IC) may include at least one cell including a plurality of conductive lines that extend in a first direction and are in parallel to each other in a second direction that is perpendicular to the first direction, first contacts respectively disposed at two sides of at least one conductive line from among the plurality of conductive lines, and a second contact disposed on the at least one conductive line and the first contacts and forming a single node by being electrically connected to the at least one conductive line and the first contacts.

Abstract: A probe system for real-time quantitative and qualitative analysis of a biomaterial, and a reaction chamber with the probe system, and an analysis method thereof are provided. The probe system, which is included in the reaction chamber having an optically transmissive flat bottom surface and having a test sample accommodated therein, includes a target probe-reporter probe linker accommodated in the reaction chamber and including a target probe, which includes a sequence complementary to a target nucleic acid sequence to be detected, a first fluorophore and a first quencher, and a reporter probe linked to an end of the target probe and including a sequence non-complementary to the target nucleic acid sequence, and a capture probe included in a biochip formed on a bottom surface of the reaction chamber and including a complementary sequence hybridizable with the non-complementary sequence of the reporter probe, a second fluorophore and a second quencher.

Abstract: The present disclosure relates to a blue complex powder including a flat-shaped fine powder and a coating layer coated on the flat-shaped fine powder and a composition for improving skin transparency which includes the blue complex powder as an active ingredient. The complex powder may provide improved naturalness, gloss and transparency by reflecting, emitting or amplifying blue light. In addition, the complex powder may provide uniform applicability on skin and uniform interference by restricting the particle size distribution of the complex powder to 1-16 ?m. The complex powder is useful because it may be used in a cosmetic composition for base makeup.